Lantus and Ear disorder - a phase IV clinical study of FDA data

Summary:

Ear disorder is reported as a side effect among people who take Lantus (insulin glargine recombinant), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humalog, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Ear disorder when taking Lantus. It is created by eHealthMe based on reports of 190,478 people who have side effects when taking Lantus from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

What is Ear disorder?

Ear disorder is found to be associated with 594 drugs and 1,106 conditions by eHealthMe. Check the latest studies of Ear disorder.

On Jul, 29, 2026

190,478 people reported to have side effects when taking Lantus.
Among them, 57 people (0.03%) have Ear disorder.

Among these 57 people:

How long have people been on Lantus when they have Ear disorder? *

What is the gender of people who have Ear disorder when taking Lantus? *

female: 75 %
male: 25 %

What is the age of people who have Ear disorder when taking Lantus? *

What are other drugs people take besides Lantus? *

What are other side effects people have besides Ear disorder? *

Blood Glucose Increased: 14 people, 24.56%
Feeling Abnormal: 13 people, 22.81%
Nausea (feeling of having an urge to vomit): 11 people, 19.30%
Weakness: 10 people, 17.54%
Weight Decreased: 9 people, 15.79%
Headache (pain in head): 9 people, 15.79%
Dizziness: 8 people, 14.04%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 14.04%
Rashes (redness): 7 people, 12.28%
Pain In Extremity: 7 people, 12.28%

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 5 people, 8.77%
Immunodeficiency Common Variable: 5 people, 8.77%
Pain: 4 people, 7.02%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 5.26%
Abdominal Discomfort: 2 people, 3.51%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 2 people, 3.51%
Gastric Disorder (disease of stomach): 2 people, 3.51%
High Blood Cholesterol: 2 people, 3.51%
Tumor: 2 people, 3.51%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 3.51%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and have Ear disorder?

- Check whether Ear disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lantus:

Lantus (191,782 reports)

Ear disorder treatments and more:

Ear disorder (6,288 reports)

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ear disorder:

Ear disorder (594 drugs)

Browse all the conditions that are associated with Ear disorder:

Ear disorder (1,106 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant (the active ingredients of Lantus) and Lantus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.